SAN FRANCISCO--(BUSINESS WIRE)--The Australian Government’s investment attraction agency, Invest Australia, today congratulated Australian pharmaceutical company Pharmaxis after it was granted FDA fast-track status for its cystic fibrosis product Bronchitol.
